{
    "2018-10-04": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Alphabet and Simon Property skid while Constellation rises",
                "features": {
                    "keywords": [
                        "skid",
                        "rises"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "real estate",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Tech Stocks Punished As Nasdaq Breaks Support; Leading Software Stocks Nailed",
                "features": {
                    "keywords": [
                        "punished",
                        "breaks support",
                        "nailed"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Notable Thursday Option Activity: HD, LLY, ADBE",
                "features": {
                    "keywords": [
                        "option activity",
                        "HD",
                        "LLY",
                        "ADBE"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "healthcare",
                        "software"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "US STOCKS-Wall St succumbs to soaring bond yields",
                "features": {
                    "keywords": [
                        "soaring bond yields",
                        "succumbs"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "financials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "XLV, UNH, MDT, LLY: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "ETF inflow",
                        "XLV",
                        "UNH",
                        "MDT",
                        "LLY"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Boehringer Ingelheim and Lilly present full results of Tradjenta®'s CARMELINA® cardiovascular outcome trial",
                "features": {
                    "keywords": [
                        "full results",
                        "Tradjenta",
                        "CARMELINA",
                        "cardiovascular"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "S&P 500 Movers: COTY, LLY",
                "features": {
                    "keywords": [
                        "movers",
                        "COTY",
                        "LLY"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Amgen’s Stock Performance and Estimates after Q3 2018",
                "features": {
                    "keywords": [
                        "stock performance",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Lilly's diabetes drug data impresses, hurts rival Novo's shares",
                "features": {
                    "keywords": [
                        "diabetes drug",
                        "impresses",
                        "hurts",
                        "Novo"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "US STOCKS-Wall St set to open lower as Treasury yields jump",
                "features": {
                    "keywords": [
                        "open lower",
                        "Treasury yields",
                        "jump"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "financials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-13",
                "original_text": "Diabetes Drug's Results Push Lilly to Look at Obesity Too",
                "features": {
                    "keywords": [
                        "diabetes drug",
                        "results",
                        "obesity"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-14",
                "original_text": "The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",
                "features": {
                    "keywords": [
                        "biotech pulse",
                        "AtriCure",
                        "Guardant Health",
                        "Kodiak"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "Eli Lilly's stock surges toward record after positive trials for diabetes treatments",
                "features": {
                    "keywords": [
                        "stock surges",
                        "record",
                        "positive trials",
                        "diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "Eli Lilly’s Stock Performance and Estimates for Q3 2018",
                "features": {
                    "keywords": [
                        "stock performance",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-17",
                "original_text": "Mylan Launches Its Generic Brevibloc Injection",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Generic Brevibloc",
                        "launch"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "Global Markets Drag Stocks Lower; Did China Hack Apple?",
                "features": {
                    "keywords": [
                        "global markets",
                        "drag",
                        "lower",
                        "China",
                        "Apple"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "global markets"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes",
                "features": {
                    "keywords": [
                        "full results",
                        "EASE",
                        "Phase III",
                        "empagliflozin",
                        "type 1 diabetes"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-20",
                "original_text": "Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes",
                "features": {
                    "keywords": [
                        "investigational",
                        "GIP",
                        "GLP-1",
                        "reduction",
                        "HbA1c",
                        "body weight",
                        "type 2 diabetes"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-21",
                "original_text": "Eli Lilly's diabetes drug shows promise in mid-stage trial",
                "features": {
                    "keywords": [
                        "diabetes drug",
                        "promise",
                        "mid-stage trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-22",
                "original_text": "Boehringer Ingelheim & Eli Lilly: Empagliflozin Meets Primary Efficacy Endpoint",
                "features": {
                    "keywords": [
                        "Empagliflozin",
                        "primary efficacy endpoint"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}